Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation

Por um escritor misterioso

Descrição

COLUMBIA, S.C. (April 30, 2021) – Ritedose, a 503B outsourcing facility located in South Carolina, just launched a new unit dose syringe product, Labetalol Hydrochloride Injection 20 mg/4 mL (5mg/mL). It is part of a 12-product, six-month rollout from Ritedose for hospital pharmacies across the coun
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Fresenius USA 63323092410 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
News – Page 2 – The Ritedose Corporation
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Pfizer 00409233934 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Fresenius USA 63323048257 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
00409-4264-01 Pfizer Hospital US
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Ritedose Pharmaceuticals 76204090001 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Ritedose Launches New 503B, Single-Dose Syringe Medications for
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Pfizer 00409488850 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
News – Page 2 – The Ritedose Corporation
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Fresenius USA 63323054505 - McKesson Medical-Surgical
Ritedose Launches New Single-Dose Syringe Product: Labetalol Hydrochloride  Injection 20 mg/4 mL (5mg/mL) – The Ritedose Corporation
Mikal Jones
de por adulto (o preço varia de acordo com o tamanho do grupo)